MY129282A - Aerosolizable particles resistant to hygroscopic growth - Google Patents

Aerosolizable particles resistant to hygroscopic growth

Info

Publication number
MY129282A
MY129282A MYPI99003947A MYPI9903947A MY129282A MY 129282 A MY129282 A MY 129282A MY PI99003947 A MYPI99003947 A MY PI99003947A MY PI9903947 A MYPI9903947 A MY PI9903947A MY 129282 A MY129282 A MY 129282A
Authority
MY
Malaysia
Prior art keywords
hygroscopic growth
particles resistant
active agent
aerosolizable particles
aerosolizable
Prior art date
Application number
MYPI99003947A
Other languages
English (en)
Inventor
Andrew Clark
Mei Chang Kuo
Cecily Lalor
Barry John Aldous
Original Assignee
Nektar Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nektar Therapeutics filed Critical Nektar Therapeutics
Publication of MY129282A publication Critical patent/MY129282A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
MYPI99003947A 1998-09-14 1999-09-13 Aerosolizable particles resistant to hygroscopic growth MY129282A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10016398P 1998-09-14 1998-09-14

Publications (1)

Publication Number Publication Date
MY129282A true MY129282A (en) 2007-03-30

Family

ID=22278404

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI99003947A MY129282A (en) 1998-09-14 1999-09-13 Aerosolizable particles resistant to hygroscopic growth

Country Status (44)

Country Link
EP (1) EP1117442A1 (lt)
JP (1) JP2002524535A (lt)
KR (1) KR20010075063A (lt)
CN (1) CN1317977A (lt)
AP (1) AP1374A (lt)
AR (1) AR022090A1 (lt)
AU (1) AU753014B2 (lt)
BG (1) BG105430A (lt)
BR (1) BR9913722A (lt)
CA (1) CA2343920A1 (lt)
CO (1) CO5130023A1 (lt)
CZ (1) CZ2001829A3 (lt)
DZ (1) DZ2892A1 (lt)
EA (1) EA003476B1 (lt)
EE (1) EE200100151A (lt)
GE (1) GEP20043257B (lt)
GT (1) GT199900156A (lt)
HK (1) HK1042231A1 (lt)
HN (1) HN1999000159A (lt)
HR (1) HRP20010189A2 (lt)
HU (1) HUP0103837A3 (lt)
ID (1) ID28845A (lt)
IL (2) IL141562A0 (lt)
IS (1) IS5878A (lt)
LT (1) LT4897B (lt)
LV (1) LV12658B (lt)
MA (1) MA25590A1 (lt)
MY (1) MY129282A (lt)
NO (1) NO20011251L (lt)
NZ (1) NZ510168A (lt)
OA (1) OA11781A (lt)
PA (1) PA8481901A1 (lt)
PE (1) PE20001061A1 (lt)
PL (1) PL195574B1 (lt)
SA (1) SA99200718B1 (lt)
SK (1) SK3442001A3 (lt)
TN (1) TNSN99173A1 (lt)
TR (1) TR200101182T2 (lt)
TW (1) TWI226248B (lt)
UA (1) UA76085C2 (lt)
UY (1) UY25711A1 (lt)
WO (1) WO2000015262A1 (lt)
YU (1) YU24201A (lt)
ZA (1) ZA200101995B (lt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
WO2000075281A2 (en) 1999-06-09 2000-12-14 University Technology Corporation Supercritical fluid-assisted nebulization and bubble drying
US6475468B2 (en) * 2001-02-15 2002-11-05 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
JP2005503425A (ja) * 2001-05-24 2005-02-03 アレックザ モレキュラー デリヴァリー コーポレイション 所定の吸入ルートによる薬剤エステルの送出
EG24184A (en) * 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
US7182961B2 (en) 2001-11-20 2007-02-27 Advanced Inhalation Research, Inc. Particulate compositions for pulmonary delivery
AU2003215396B2 (en) 2002-02-25 2010-04-08 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
JP2006513139A (ja) * 2002-07-03 2006-04-20 ザ・ブリガーム・アンド・ウーメンズ・ホスピタル・インコーポレーテッド 治療薬の全身性送達のための中央部気道投与
WO2004060352A1 (en) * 2002-12-19 2004-07-22 Pharmacia Corporation Non-hygroscopic formulation comprising a hydroscopic drug
DE10338403A1 (de) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverformulierung, enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl]-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyrindinyl)-piperazin, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
AU2005237523A1 (en) * 2004-04-23 2005-11-10 Cydex Pharmaceuticals, Inc. DPI formulation containing sulfoalkyl ether cyclodextrin
UA95903C2 (ru) 2005-02-24 2011-09-26 Дифьюжен Фармасьютикалз Ллк Транс-каротиноиды, их синтез, лекарственная форма и применение
KR20070110418A (ko) * 2005-03-09 2007-11-16 오노 야꾸힝 고교 가부시키가이샤 입자 및 그 입자를 함유하는 제제
MX383536B (es) 2005-10-26 2025-03-14 Cydex Pharmaceuticals Inc Composiciones de éter sulfoalquílico-ciclodextrina y métodos de preparación de las mismas.
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
WO2008021451A2 (en) * 2006-08-14 2008-02-21 Aktiv-Dry Llc Human-powered dry powder inhaler and dry powder inhaler compositions
CN101541311B (zh) * 2006-10-25 2013-01-23 大日本住友制药株式会社 不易结块的颗粒制剂
EP1925295A1 (de) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Stabile Pulverformulierung enthaltend ein Anticholinergikum
KR101570131B1 (ko) 2007-04-13 2015-11-18 디퓨젼 파마슈티컬즈 엘엘씨 양극성 트랜스 카로티노이드의 말초혈관질환 치료와 예방을 위한 용도
US12370352B2 (en) 2007-06-28 2025-07-29 Cydex Pharmaceuticals, Inc. Nasal and ophthalmic delivery of aqueous corticosteroid solutions
JP2011502125A (ja) 2007-10-31 2011-01-20 ディフュージョン・ファーマシューティカルズ・エルエルシー 小分子拡散を促進する新しい種類の治療法
PL2432502T3 (pl) 2009-05-20 2018-05-30 Aeras Trwałe, suszone rozpyłowo, immunogenne kompozycje wirusowe
CN108464976A (zh) 2009-06-22 2018-08-31 扩散药品有限公司 扩散促进化合物及其单独或与溶栓药一起的应用
WO2011152869A1 (en) 2010-06-02 2011-12-08 Diffusion Pharmaceuticals Llc Oral formulations of bipolar trans carotenoids
CA2866230C (en) 2012-05-03 2020-08-18 Janssen R&D Ireland Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections
WO2014074797A1 (en) * 2012-11-09 2014-05-15 Civitas Therapeutics, Inc. Ultra low density pulmonary powders
US20180043585A9 (en) * 2013-09-20 2018-02-15 Virginia Commonwealth University Delivery of particles using hygroscopic excipients
DK3212212T3 (da) 2014-10-31 2020-12-21 Univ Monash Pulverformulering
CN115089569A (zh) 2016-03-24 2022-09-23 扩散药品有限公司 双极性反式类胡萝卜素连同化疗和放射治疗在治疗癌症中的用途
US20220378727A1 (en) * 2021-05-14 2022-12-01 The University Of Hong Kong Dry powder formulations of tamibarotene for pulmonary and intranasal delivery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155573A (en) * 1958-05-06 1964-11-03 Benger Lab Ltd Inhalant composition and method of making same
CA2115065C (en) * 1992-06-12 2000-10-03 Kiyoyuki Sakon Ultrafine particle powder for inhalation and method for production thereof
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
PT954282E (pt) * 1997-01-16 2005-06-30 Massachusetts Inst Technology Preparacao de particulas para inalacao
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

Also Published As

Publication number Publication date
EA003476B1 (ru) 2003-06-26
CO5130023A1 (es) 2002-02-27
SA99200718B1 (ar) 2006-11-04
IS5878A (is) 2001-03-05
EP1117442A1 (en) 2001-07-25
SK3442001A3 (en) 2001-11-06
GEP20043257B (en) 2004-06-25
UY25711A1 (es) 1999-11-17
LT4897B (lt) 2002-02-25
AU6039799A (en) 2000-04-03
DZ2892A1 (fr) 2003-12-15
HUP0103837A2 (hu) 2002-05-29
ID28845A (id) 2001-07-05
HRP20010189A2 (en) 2005-04-30
HUP0103837A3 (en) 2002-11-28
AU753014B2 (en) 2002-10-03
CN1317977A (zh) 2001-10-17
MA25590A1 (fr) 2002-12-31
OA11781A (en) 2005-07-26
TWI226248B (en) 2005-01-11
KR20010075063A (ko) 2001-08-09
NO20011251D0 (no) 2001-03-13
LT2001021A (lt) 2001-11-26
TR200101182T2 (tr) 2001-09-21
PL346768A1 (en) 2002-02-25
LV12658B (lv) 2001-09-20
CA2343920A1 (en) 2000-03-23
IL141562A (en) 2007-07-24
HN1999000159A (es) 1999-11-11
EA200100300A1 (ru) 2001-10-22
PA8481901A1 (es) 2002-04-25
GT199900156A (es) 2001-03-07
YU24201A (sh) 2003-08-29
EE200100151A (et) 2002-06-17
ZA200101995B (en) 2002-03-11
AR022090A1 (es) 2002-09-04
NO20011251L (no) 2001-04-17
AP2001002093A0 (en) 2001-03-31
PE20001061A1 (es) 2000-10-08
IL141562A0 (en) 2002-03-10
AP1374A (en) 2005-02-28
BR9913722A (pt) 2001-05-29
UA76085C2 (en) 2006-07-17
HK1042231A1 (zh) 2002-08-09
JP2002524535A (ja) 2002-08-06
PL195574B1 (pl) 2007-10-31
WO2000015262A1 (en) 2000-03-23
LV12658A (lv) 2001-05-20
NZ510168A (en) 2003-09-26
BG105430A (en) 2001-12-29
CZ2001829A3 (cs) 2001-09-12
TNSN99173A1 (fr) 2005-11-10

Similar Documents

Publication Publication Date Title
MY129282A (en) Aerosolizable particles resistant to hygroscopic growth
NZ511527A (en) Dry powder for inhalation
MY129112A (en) Flow resistance modulated aerosolized active agent delivery
HU9201521D0 (en) Stimulating unit containing nicotine
GB1484781A (en) Compositions for dental treatment
CA2412561A1 (en) Highly efficient delivery of a large therapeutic mass aerosol
PL343342A1 (en) Particulate active agent support for pulmonary application
NZ333724A (en) Enhancing lean tissue mass and bone mineral content by the administration of calcium compositions
ATE150310T1 (de) Oral anzuwendende suspension bestehend aus stabilisiertem rockenpulver eines hydratisierten cephalosporins
ID22883A (id) Formulasi untuk inhalasi yang memiliki densitas ruah terlimpah antara 0,28 sampai 038 g/ml dan mengandung budesonida
DE69806362D1 (de) Therapeutische pulverformulierung zur pulmonaren anwendung, welche kristallines insulin enthält
MXPA03003785A (es) Suspension de una proteina epi-hne, proceso de preparacion de la misma, aerosol en polvo seco derivado de la misma, composiciones farmaceuticas conteniendo dicha suspension o aerosol y sus usos.
WO2005039288A3 (en) An insectidcidal composition with enhanced synergistic activity
PL365736A1 (en) Bimodal dry powder formulation for inhalation
SE8300495D0 (sv) Improvements in or relating to nasal pharmaceutical compositions
TH51990A3 (th) การปล่อยสารออกฤทธิ์ที่เป็นผงแห้ง
SE9302198D0 (sv) Powder preparation for inhalation
PL397707A1 (pl) Zastosowanie kompozycji herbicydów do zwalczania szkodliwych roślin w uprawach zbóż, sposób zwalczania szkodliwych roślin w tolerujących uprawach zbóż i środek chwastobójczy